Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA says commonly used decongestant 'not effective,' proposes removal
Nov. 7 (UPI) --The U.S. Food and Drug Administration has determined commonly used oral phenylephrine is "not effective" and has proposed its removal from over-the-counter nasal
decongestants
. "It is the
FDA
's role to ensure that drugs are safe and ...
FDA proposes oral phenylephrine, found in many decongestants, pulled from shelves
The Food and Drug Administration proposed that oral phenylephrine be removed from store shelves saying that the treatment does not work.
FDA moves to pull popular decongestant from shelves amid effectiveness concerns
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular over-the-counter
decongestants
– from ... as a nasal decongestant for decades. The
FDA
’s proposal isn’t an immediate order ...
These Over-The-Counter Decongestants Don't Work, FDA Says
A common ingredient found in most oral over-the-counter cold medicines should be removed from the market because it doesn’t work, the Food and Drug Administration (
FDA
) says. This follows an extensive review that found the drug ineffective for treating ...
FDA proposes removing popular decongestant found in cold meds
The Food and Drug Administration (FDA) is proposing to officially remove a popular ingredient in many cold and allergy medications – oral phenylephrine.
USFDA proposes removal of common decongestant from shelves after finding it ineffective
The FDA would provide manufacturers with appropriate time to either reformulate drugs containing oral phenylephrine or remove such drugs from the market, it stated.
FDA proposes pulling common decongestant from shelves
Over-the-counter medications containing phenylephrine may remain on the market as the FDA seeks public comment on the proposed order. After reviewing comments, the FDA will determine whether to issue a final order revoking oral phenylephrine's classification as "generally recognized as safe and effective."
U.S. FDA proposes ending use of popular decongestant present in cold medicines
(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups, as an active ingredient in over-the-counter drugs for nasal congestion,
FDA proposes removing ineffective decongestant found in most cold medicine
The Food and Drug Administration (FDA) is proposing the removal from the market of a common ingredient found in most oral over-the-counter cold medicines because it doesn’t work.
FDA Proposes Ban on a 'Useless' Decongestant, Phenylephrine
More than a year after its advisory panel unanimously declared the drug phenylephrine to be useless against nasal congestion, the U.S. Food and Drug Administration is proposing that it be removed from common over-the-counter decongestants.
14h
on MSN
FDA wants to remove popular decongestants from stores permanently that contain this ingredient
The Food and Drug Administration says it wants to remove some of the most popular over-the-counter decongestants that have a ...
Atlanta Journal-Constitution
1h
FDA wants to halt sales of decongestants containing ineffective phenylephrine
Just as cold and flu season arrives, the Food and Drug Administration proposes pulling many
decongestants
from store shelves ... For some products, it is the only ingredient, the
FDA
said in a ...
CBS News on MSN
22h
FDA to pull common but ineffective cold medicine from market
The
FDA
's proposal comes more than a year after the agency's ... A number of common over-the-counter nasal
decongestants
...
NBC News on MSN
21h
FDA proposes ending use of decongestant found in many cold, allergy medicines
The
FDA
said the proposed order is not based on safety concerns ... It also found people prefer oral
decongestants
over ...
7d
Litigators of the Week: An Early Knockout Win in the Decongestant MDL
After Andrew Soukup of Covington & Burling and Jay Lefkowitz of Kirkland & Ellis argued the motion to dismiss for the ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback